| Title |
Publication Date |
Interest Group & Committee |
Copyright |
| Guidelines for CSCC Endorsement of Publications |
Dec 2024 |
|
|
| Consensus Considerations and Good Practice Points for Use of Continuous Glucose Monitoring Systems in Hospital Settings |
Dec 2024 |
POCT SIG |
Diabetes Care 2024;47(12):2062–2075. |
| Canadian Society of Clinical Chemists Harmonized Pediatric Lipid Reporting Recommendations for Clinical Laboratories |
July 2024 |
Harmonization of Reference Interval Working Group |
Canadian Journal of Cardiology
Volume 40, Issue 7, July 2024, Pages 1183-1197. |
| Choosing Wisely Clinical Biochemistry Recommendations – Twelve Tests and Treatments to Question |
May 2024 |
Utilization Management SIG |
Choosing Wisely Canada |
| Establishing quality indicators for point of care glucose testing: recommendations from the Canadian Society for Clinical Chemists Point of Care Testing and Quality Indicators Special Interest Groups |
April 2023 |
POCT & Quality Indicators SIG |
Clinical Chemistry and Laboratory Medicine (CCLM), Volume 61, Issue 7, Pages 1280-1287. |
| Reduce, Reuse, Recycle: Top 10 Choosing Wisely Canada’s Recommendations for Conserving Laboratory Resources |
Nov 2022 |
Utilization Management SIG |
Canadian Journal General Internal Medicine, Volume 17, Issue 4, Pages 86-95. |
| Canadian Society of Clinical Chemists Harmonized Clinical Laboratory Lipid Reporting Recommendations on the Basis of 2021 Canadian Cardiovascular Society Lipid Guidelines |
Aug 2022 |
Harmonization of Reference Interval Working Group |
Canadian Journal of Cardiology, Volume 38, Issue 8, Pages 1180-1188. |
| Intrapartum Fetal Scalp Lactate Testing: Considerations for Implementation and Clinical Decision Making |
Nov 2021 |
POCT SIG |
J OBstet Gynaecol Can., Volume 43, Issue 11, Pages 1244-1246. |
| Canadian Society of Clinical Chemists (CSCC) consensus guidance for testing, selection, and quality management of SARS-CoV-2 point-of-care tests |
Sept 2021 |
COVID-19/POCT SIG |
Clinical Biochemistry, Volume 95, Pages 1-12. |
| AACC Practical Recommendations for Implementing and Interpreting SARS-CoV-2 Emergency Use Authorization and Laboratory Developed Test Serologic Testing in Clinical Laboratories |
Sept 2021 |
COVID-19 SIG |
Clinical Chemistry, Volume 67, Issue 9, Pages 1188-1200. |
| Quality assurance practices for point of care testing programs: Recommendations by the Canadian society of clinical chemists point of care testing interest group |
Feb 2021 |
POCT SIG |
Clinical Biochemistry, Volume 88, Pages 11-17. |
| Canadian Society of Clinical Chemists (CSCC) interim consensus guidance for testing and reporting of SARS-CoV-2 serology |
Dec 2020 |
COVID-19 SIG |
Clinical Biochemistry, Volume 86, Pages 1-7. |
| Interim guidance on the use of the Abbott ID NOWTM instrument and COVID-19 assay on behalf of the Canadian Public Health Laboratory Network and the Canadian Society of Clinical Chemists |
Nov 2020 |
COVID-19 SIG |
Can Commun Dis Rep, Volume 46, Issue 11/12, Pages 422-426. |
| Point-of-care testing: A position statement from the Canadian Society of Clinical Chemists |
Mar 2018 |
POCT SIG |
Clinical Biochemistry, Volume 53, Pages 156-159. |
| Candidate recommendations for protein electrophoresis reporting from the Canadian Society of Clinical Chemists Monoclonal Gammopathy Working Group |
Jan 2018 |
Monoclonal Gammopathy SIG |
Clinical Biochemistry, Volume 51, Pages 10-20. |
| Cardiac troponin testing in the acute care setting: Ordering, reporting, and high sensitivity assays – an update from the Canadian Society of Clinical Chemists (CSCC) |
Nov 2018 |
|
Clinical Biochemistry, Volume 44, Issue 16, Pages 1273 – 1277. |
